• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA 突变型胰腺癌维持奥拉帕利治疗时发生的不常见转移:两例病例报告并文献复习。

Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature.

机构信息

Departement of Medical Oncolgy, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Department of Gastroenterology, Hepatopancreatology, and Digestive Oncology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

Eur J Cancer. 2021 Nov;157:63-67. doi: 10.1016/j.ejca.2021.07.042. Epub 2021 Sep 4.

DOI:10.1016/j.ejca.2021.07.042
PMID:34487986
Abstract

The most common metastatic sites of pancreatic cancer are the liver, lymph nodes, peritoneum and lung. Here we report two cases of BRCA mutated pancreatic cancer that developed unusual metastasis while treatment with maintenance Olaparib and leading to rapid death. We hereby review the literature and address the possibility of a different nature and tumour biology of BRCA mutated cancer treated with PARP inhibitors.

摘要

胰腺癌最常见的转移部位是肝脏、淋巴结、腹膜和肺。在这里,我们报告了两例携带 BRCA 突变的胰腺癌病例,在接受奥拉帕利维持治疗时出现了不常见的转移,并导致迅速死亡。我们在此回顾文献,并探讨了接受 PARP 抑制剂治疗的 BRCA 突变型癌症是否具有不同的性质和肿瘤生物学。

相似文献

1
Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature.BRCA 突变型胰腺癌维持奥拉帕利治疗时发生的不常见转移:两例病例报告并文献复习。
Eur J Cancer. 2021 Nov;157:63-67. doi: 10.1016/j.ejca.2021.07.042. Epub 2021 Sep 4.
2
Maintenance Olaparib for Germline -Mutated Metastatic Pancreatic Cancer.维持奥拉帕利治疗种系突变转移性胰腺癌。
N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.
3
A new targeted treatment for patients with a germline mutation: olaparib in pancreatic cancer.一种针对胚系突变患者的新靶向治疗方法:奥拉帕利在胰腺癌中的应用。
Future Oncol. 2020 Nov;16(33):2691-2700. doi: 10.2217/fon-2020-0334. Epub 2020 Aug 17.
4
[New drug approval: Olaparib - pancreatic cancer with BRCA germline mutation].[新药批准:奥拉帕利——用于携带BRCA种系突变的胰腺癌]
Bull Cancer. 2020 Oct;107(10):961-962. doi: 10.1016/j.bulcan.2020.06.009. Epub 2020 Sep 14.
5
A case report of a dramatic response to olaparib in a patient with metastatic pancreatic cancer harboring a germline BRCA2 mutation.一名携带胚系BRCA2突变的转移性胰腺癌患者对奥拉帕尼产生显著反应的病例报告。
Medicine (Baltimore). 2019 Oct;98(40):e17443. doi: 10.1097/MD.0000000000017443.
6
An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer.奥拉帕利单药治疗经大量预处理的 BRCA2 突变转移性胰腺癌:意料之外的肿瘤缩小。
Curr Oncol. 2022 Jan 27;29(2):544-550. doi: 10.3390/curroncol29020049.
7
A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.一名转移性胰腺癌患者中存在新型种系 BRCA2 点突变:病例报告。
BMC Med Genomics. 2021 Jan 6;14(1):6. doi: 10.1186/s12920-020-00850-6.
8
Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.维持奥拉帕利治疗种系 BRCA 突变转移性胰腺癌的成本效益。
J Natl Compr Canc Netw. 2020 Nov 2;18(11):1528-1536. doi: 10.6004/jnccn.2020.7587. Print 2020 Nov.
9
Comparative efficacy, safety, and acceptability of single-agent poly (ADP-ribose) polymerase (PARP) inhibitors in -mutated -negative metastatic or advanced breast cancer: a network meta-analysis.单药聚 ADP-核糖聚合酶(PARP)抑制剂在 BRCA1/2 突变阴性转移性或晚期乳腺癌中的疗效、安全性和可接受性的比较:一项网络荟萃分析。
Aging (Albany NY). 2020 Nov 30;13(1):450-459. doi: 10.18632/aging.202152.
10
Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts.电离辐射与PARP抑制剂奥拉帕利联合治疗对BRCA突变型和野生型患者来源的胰腺癌异种移植瘤的影响。
PLoS One. 2016 Dec 29;11(12):e0167272. doi: 10.1371/journal.pone.0167272. eCollection 2016.

引用本文的文献

1
A Rare Case of Simultaneous Brain and Leptomeningeal Metastases in a Patient With Pancreatic Cancer.一例胰腺癌患者同时发生脑和软脑膜转移的罕见病例。
Cureus. 2025 Mar 2;17(3):e79923. doi: 10.7759/cureus.79923. eCollection 2025 Mar.
2
Skin metastasis of BRCA mutated prostate cancer: A case report and a brief review of literature.BRCA 基因突变型前列腺癌皮肤转移:病例报告及文献复习。
Medicine (Baltimore). 2024 Oct 11;103(41):e40016. doi: 10.1097/MD.0000000000040016.
3
A Unique Case of a Patient With Pancreatic Cancer Developing Leptomeningeal Metastases While on Gemcitabine and Nab-Paclitaxel.
一名胰腺癌患者在接受吉西他滨和纳米白蛋白结合型紫杉醇治疗时发生软脑膜转移的独特病例。
Cureus. 2024 Apr 12;16(4):e58139. doi: 10.7759/cureus.58139. eCollection 2024 Apr.